|
| Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Bullion ~ Forex ~ Sports ~ Technology ~ Health ~ Features |
| Lung Cancer ~ Lung Cancer ~ Breast Cancer ~ Heart attack ~ All Health Topics |
|
Home
/ Health News / 2008 / August 2008 / August 28, 2008 Giving up statins doubles heart attack patients death risk |
Yeast studies provide clue about controlling cholesterol levels
Protein behind hearts tick-tock identified
Extract of the plant cats claw may harbour dengue cure
A plant from the Amazon region called the cats claw has been found to be effective in combating dengue. ANI
Yeast studies provide clue about controlling cholesterol levels
Johns Hopkins researchers say that they have gained significant insights into the mechanism whereby a single-celled fungus regulates its version of cholesterol. ANI
Stress-related disorders deteriorates brains memory processing ability
Using functional MRI (fMRI), a researcher team, which was led by an Indian-origin scientist, has found that patients suffering from stress-related psychiatric disorders have impaired wiring in the area of the brain behind suppressing memory. ANI
Heart patients who stop taking statins after suffering a heart attack are increasing their risk of dying over the next year, suggests a new study.
Washington, Aug 28 : Heart patients who stop taking statins after suffering a heart attack are increasing their risk of dying over the next year, suggests a new study.
Researchers at McGill University and the McGill University Health Centre (MUHC) used the data on British patients who survived an acute myocardial infarction and were still alive three months.
They found that those who discontinued their statin medication were 88pct more likely to die during the following year compared to those who had never been on the medication.
"Statins were found to be beneficial drugs," said lead researcher Stella Daskalopoulou, McGill's Faculty of Medicine and the Department of Medicine and the Division of Clinical Epidemiology at the MUHC.
"Patients who used statins before an AMI and continued to take them after were 16pct less likely to die over the next year than those who never used them.
"So even if it appears that the statins failed to prevent your AMI, it is beneficial to continue taking them and potentially quite harmful to stop," she added.
Daskalopoulou said that in the general population the statin discontinuation rate within the first year of prescription is 30 percent.
"That's very high because statins are preventative drugs, patients may not feel the immediate benefit of taking them and sometimes stop. However, it looks like this might be quite a dangerous practice after an AMI," she said.
The researchers suggest that harmful effects of statin discontinuation may be the result of many different mechanisms, including individual patient characteristics.
"Patients also need to take their medications exactly as prescribed after an AMI. Statins in particular should only be withdrawn after an AMI under close clinical supervision," she added.
ANI
